Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05795179 · ClinicalTrials.gov registry record · NA

Stress & Self-Control Costs

A NA study of Self-Control, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT05795179: Recruiting NA study of Self-Control, sponsored by NYU Langone Health.

NCT05795179 is a NA study of Self-Control that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 300 participants, below the 472-participant average among 3 other Self-Control trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05795179, a NA study of Self-Control, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

Self-control failures are a universal challenge for healthy and clinical populations. Recent work suggests these failures may arise from excessive cognitive costs associated with exercising self-control, yet the mechanisms underlying these costs are unknown. To address this, the investigators will use a validated decision-making task that measures how much individuals will pay (from a study endowment) to restrict access to tempting rewards that may lead to self-control failures. The investigators will examine these costs to identify their cognitive, neural and affective mechanisms. First, the investigators will identify the cognitive and computational mechanism that gives rise to self-control costs. Second, the investigators will characterize the neural correlates of self-control costs and identify neural mediators and connectivity patterns stemming from these costs. Finally, the investigators will examine how different classes of stressors (physical, social, or lifetime stress) shape the behavioral and neural representations of self-control costs.

Primary Outcome

The self-control cost is the amount that a participant would be willing to pay to avoid temptation. This will be tested in a self-control task in which participants are shown an images of snack food and report how much they would be willing to avoid the different food items.

Conditions Studied

Interventions

  • BEHAVIORAL Trier Social Stress Test (TSST)
  • DEVICE Functional Magnetic Resonance Imaging (fMRI)
  • BEHAVIORAL Cold-Pressor Task (CPT)
  • BEHAVIORAL Modified Non-Stress CPT
  • BEHAVIORAL Modified Non-Stress TSST

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-10-01
Est. Completion 2028-04-01
Phase NA
NYU Langone Health

1,164 total trials

What NCT05795179 shows while recruiting

NCT05795179 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 472-participant average among 3 other Self-Control trials with a reported enrollment target (36% lower).

The record links to 1 condition, with Self-Control appearing as the primary indexed condition, and to 5 interventions - of which Trier Social Stress Test (TSST) is the first listed.

NCT05795179 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05795179 about?

NCT05795179 is a clinical study titled "Stress & Self-Control Costs". Self-control failures are a universal challenge for healthy and clinical populations. Recent work suggests these failures may arise from excessive cognitive costs associated with exercising self-control, yet the mechanisms underlying these costs are unknown. To address this, the investigators will u...

What is the current status of trial NCT05795179?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-10-01. Estimated completion is 2028-04-01.

What conditions does trial NCT05795179 study?

This clinical trial studies the following conditions: Self-Control.

What interventions are being tested in trial NCT05795179?

The interventions under investigation include: Trier Social Stress Test (TSST) (BEHAVIORAL), Functional Magnetic Resonance Imaging (fMRI) (DEVICE), Cold-Pressor Task (CPT) (BEHAVIORAL), Modified Non-Stress CPT (BEHAVIORAL), Modified Non-Stress TSST (BEHAVIORAL).

Who is sponsoring clinical trial NCT05795179?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05795179 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Self-Control

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05795179, the US trial registry maintained by the National Library of Medicine. NCT05795179 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.